Ferhat Isik
Overview
Explore the profile of Ferhat Isik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oksul M, Bilge O, Turken A, Isik F, Akyuz A, Cap M, et al.
Cureus
. 2023 Mar;
15(2):e34600.
PMID: 36883071
Background: Myotonic dystrophy type 1(MD1), which is characterized by decreased muscle tone, progressive muscle weakness, and cardiac involvement, is an autosomal dominant and progressive congenital muscle disease. Cardiac involvement more...
2.
Akyuz A, Isik F
Cureus
. 2022 Sep;
14(8):e28176.
PMID: 36148183
Introduction The non-dipper hypertension (HT) pattern is associated with more end-organ damage and cardiovascular events than is dipper HT. Inflammation is widely established to play a role in the pathophysiology...
3.
Akyuz A, Cap M, Varsak S, Isik F, Turken A, Tastan E, et al.
J Clin Ultrasound
. 2022 Sep;
50(9):1242-1248.
PMID: 36074078
Purpose: Cardiac involvement in limb-girdle muscular dystrophy (LGMD)2A and LGMD2B, the most common subgroups of LGMD, is controversial. Our study aims to determine whether myocardial dysfunction develops in LGMD2A and...
4.
Isik F, Soner S
Cureus
. 2022 Aug;
14(7):e26833.
PMID: 35974845
Background: Despite effective interventional treatments, the mortality of acute ST-segment elevation myocardial infarction (STEMI) is still high. Several mortality predictors are known in STEMI. Platelet-to-hemoglobin ratio (PHR) is a recently...
5.
Isik F, Akyuz A, Cap M, Turken A, Varsak S, Baysal E
Anatol J Cardiol
. 2022 Jul;
26(7):525-531.
PMID: 35791708
Background: Facioscapulohumeral muscular dystrophy is one of the most common congenital muscle disorders. Whether facioscapulohumeral muscular dystrophy causes cardiac involvement is still controversial. Although electrocardiography and conventional echocardiography studies have...
6.
Aslan B, Isik F, Akyuz A, Inci U, Karadeniz M
Int J Clin Pract
. 2022 Jun;
2022:4626701.
PMID: 35685567
Background: The coronary slow flow phenomenon (CSFP) is an atherosclerotic process that causes ischemia at the microvascular level. The CSFP may affect P wave durations, especially P wave peak time...
7.
Bilge O, Komek H, Kepenek F, Tastan E, Gundogan C, Tatli I, et al.
Nucl Med Commun
. 2022 May;
43(7):756-762.
PMID: 35506288
Objective: We aimed to examine the effects of COVID-19 pneumonia on cardiac ischemia detected by myocardial perfusion imaging with single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in patients presenting...
8.
Bilge O, Cap M, Kepenek F, Erdogan E, Tatli I, Ozturk C, et al.
Acta Cardiol
. 2022 Apr;
77(8):693-698.
PMID: 35451344
Background: Thrombolysis in Myocardial Infarction Frame Count (TFC) is an index that provides a quantitative evaluation of coronary microvascular dysfunction. In this study, we aimed to examine the effect of...
9.
Cap M, Akyuz A, Isik F, Turken A, Erdogan E, Varsak S, et al.
J Cardiovasc Echogr
. 2022 Mar;
31(4):214-219.
PMID: 35284221
Background: Congenital myopathies (CMs) are a group of rare genetic muscle disorders. Cardiac involvement can be seen in these patients. We aimed to evaluate the myocardial strain parameters by 2D...
10.
Aslan B, Akyuz A, Isik F, Boyraz B, Inci U, Yildiz H, et al.
Pacing Clin Electrophysiol
. 2022 Feb;
45(3):323-329.
PMID: 35175628
Background: Empagliflozin is a selective SGLT2 inhibitor and provides a significant reduction in hospitalizations in heart failure patients and a reduction in combined cardiovascular deaths regardless of diabetes. The mechanisms...